FOR IMMEDIATE DISTRIBUTION
SBH Science Announces the Implementation of Novel Immunoassay Testing Platform
(Natick, MA, USA) July 1, 2014. SBH Sciences, an innovative pre-clinical contract research organization, announced today that they have increased their service offerings through the addition of a newly introduced immunoassay-testing platform, the CyPlex™. The new platform was developed by CyVek, Inc, a CT based biotech firm that transforming immunoassay testing by delivering an advanced, fully automated, multi-analyte bench top immunoassay system that integrates a microfluidic cartridge with a state-of-the-art analyzer. CyPlex's ability to provide "sample to answer" test results with precision and accuracy in a sealed disposable device makes it broadly applicable across numerous sectors, including clinical applications and routine life sciences research.
The collaboration between CyVek, Inc and SBH Sciences has begun with the first placement of the novel CyPlex™ System in the United States.
Dr. Raphael Nir, President and Chief Science Officer, SBH Sciences, said: "We are excited and proud to be the first CRO to add this innovative analytical tool to our services list. We are routinely using the Luminex and it would be interesting to compare the 10 plus year platform to the new most advanced multi-analyte bench top immunoassay system. It is our strategy whenever feasible, to offer the most advanced service to the biotech industry. We are obligated to provide our products and services at a very reasonable cost and with a prompt delivery time. We are willing to assist any company that would like to qualify / validate the new platform for their specific needs. We are amongst the world experts in cytokine research and we are welcoming new collaborative research studies. This new tool will substantially increase our capabilities".
Bill Dubiel, Chief Commercial Officer, CyVek, Inc., said: "From our first meeting with SBH Sciences, Raphael clearly saw how this new technology might help his business model. We are excited to work together with SBH Sciences' CLIA-certified facility to move the CyPlex™ system to the next level of testing.
CyVek is a privately funded biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology, CyPlexTM for performing multi-analyte immunoassays. CyPlex™ is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. For more information about CyVek, please call 203-679-0395 or visit us on the web at www.cyplexsystems.com.
About SBH Sciences, Inc.
SBH Sciences is an innovative pre-clinical contract research organization, located in Natick, Massachusetts. SBH Sciences has been chosen by over 120 biotechnology and pharmaceutical companies for their service needs since 1997. SBH Sciences is also the leader of a network of specialized technology partners and provides incubator-style support to startup companies.
SBH Science's unique in-vitro lead drug optimization, cytokines production and cell-based assays, multiplex biomarker analysis and customized biological production including recombinant proteins, glycosyltransferases and monoclonal antibodies enhance discovery and bio-pharmaceutical development mainly in oncology and inflammation research and assisted its customers to reach their clinical development goals. For more information about SBH Sciences please call 508-650-6218 Ext. 214 or visit us on the web at: www.sbhsciences.com